Literature DB >> 10614822

Prion rods contain an inert polysaccharide scaffold.

T R Appel1, C Dumpitak, U Matthiesen, D Riesner.   

Abstract

A polysaccharide consisting of mainly 1,4-linked glucose units was found associated with prion rods, which are composed mainly of insoluble aggregates of the N-terminally truncated prion protein (PrP 27-30) exhibiting the ultrastructural and tinctorial properties of amyloid. The polysaccharide differs in composition from the Asn-linked oligosaccharides and the GPI-anchor of the prion protein. Prion rods were prepared from scrapie-infected hamster brains using two different purification protocols. Prolonged digestion of rods with proteinase K reduced PrP by a factor of at least 500, leaving about 10% (w/w) of the sample as an insoluble remnant. Only glucose was obtained by acid hydrolysis of the remnant and methylation analysis showed 80% 1,4-, 15% 1,6- and 5% 1,4,6-linked glucose units. The physical and chemical properties as well as the absence of terminal glucose units indicate a very high molecular mass of the polysaccharide. No evidence was found for covalent bonds between PrP and the polysaccharide. The polysaccharide certainly contributes to the unusual chemical and physical stability of prion rods, acting like a scaffold. A potential structural and/or functional relevance of the polysaccharide scaffold is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614822     DOI: 10.1515/BC.1999.165

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

1.  Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Authors:  C Wong; L W Xiong; M Horiuchi; L Raymond; K Wehrly; B Chesebro; B Caughey
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Autocatalytic self-propagation of misfolded prion protein.

Authors:  Jan Bieschke; Petra Weber; Nikolaus Sarafoff; Michael Beekes; Armin Giese; Hans Kretzschmar
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

3.  A simplified recipe for prions.

Authors:  Kil Sun Lee; Byron Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

4.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

5.  Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Authors:  Roger A Moore; Andrew G Timmes; Phillip A Wilmarth; David Safronetz; Suzette A Priola
Journal:  Proteomics       Date:  2011-09-07       Impact factor: 3.984

Review 6.  Prion protein interactions with nucleic acid: possible models for prion disease and prion function.

Authors:  Abraham Grossman; Brian Zeiler; Victor Sapirstein
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

7.  Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations.

Authors:  Roger A Moore; Andrew Timmes; Phillip A Wilmarth; Suzette A Priola
Journal:  Proteomics       Date:  2010-08       Impact factor: 3.984

Review 8.  Prion infection: seeded fibrillization or more?

Authors:  Eva Birkmann; Detlev Riesner
Journal:  Prion       Date:  2008-04-23       Impact factor: 3.931

9.  Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.

Authors:  Young Pyo Choi; Mark W Head; James W Ironside; Suzette A Priola
Journal:  Am J Pathol       Date:  2014-09-30       Impact factor: 4.307

10.  Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrPSc.

Authors:  Fei Wang; Xinhe Wang; Romany Abskharon; Jiyan Ma
Journal:  Acta Neuropathol Commun       Date:  2018-04-24       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.